114 related articles for article (PubMed ID: 16880076)
1. HIV-related liver disease: infections versus drugs.
Sidiq H; Ankoma-Sey V
Gastroenterol Clin North Am; 2006 Jun; 35(2):487-505. PubMed ID: 16880076
[TBL] [Abstract][Full Text] [Related]
2. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
3. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
4. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
Neuman MG; Monteiro M; Rehm J
Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
[TBL] [Abstract][Full Text] [Related]
5. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
6. Management of chronic hepatitis B and C in HIV-coinfected patients.
Soriano V; Barreiro P; Nuñez M
J Antimicrob Chemother; 2006 May; 57(5):815-8. PubMed ID: 16556638
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic infections update.
Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
[TBL] [Abstract][Full Text] [Related]
8. Viral hepatitis and HIV coinfection.
Sulkowski MS
J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
[TBL] [Abstract][Full Text] [Related]
10. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
Bellini C; Keiser O; Chave JP; Evison J; Fehr J; Kaiser L; Weber R; Vernazza P; Bernasconi E; Telenti A; Cavassini M;
HIV Med; 2009 Jan; 10(1):12-8. PubMed ID: 18795964
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
12. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
Halota W; Pawłowska M
Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
[TBL] [Abstract][Full Text] [Related]
13. Do HIV care providers appropriately manage hepatitis B in coinfected patients treated with antiretroviral therapy?
Jain MK; Opio CK; Osuagwu CC; Pillai R; Keiser P; Lee WM
Clin Infect Dis; 2007 Apr; 44(7):996-1000. PubMed ID: 17342656
[TBL] [Abstract][Full Text] [Related]
14. HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article.
Petrovic LM
Liver Int; 2007 Jun; 27(5):598-606. PubMed ID: 17498243
[TBL] [Abstract][Full Text] [Related]
15. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
[TBL] [Abstract][Full Text] [Related]
17. Current treatment of HIV/hepatitis B virus coinfection.
Iser DM; Sasadeusz JJ
J Gastroenterol Hepatol; 2008 May; 23(5):699-706. PubMed ID: 18410604
[TBL] [Abstract][Full Text] [Related]
18. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
19. Management of hepatitis B virus in HIV-positive patients.
Shire NJ; Sherman KE
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):67-87. PubMed ID: 16554708
[TBL] [Abstract][Full Text] [Related]
20. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
Cooper CL; Mills E
Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
